FDA drive to strengthen blood safety protocols across Karnataka
BENGALURU: For the first time, Food Safety and Drug Administration department (FDA) launched a drive earlier this week to inspect blood banks across the state to see lapses, if any, in storage methods and to verify compliance with mandatory testing protocols.
Nearly 80 blood banks have been inspected so far as part of FDA's drive.
The Food Safety Department, which has been merged with the Drug Administration, launched this drive as blood and its components are legally classified as 'drugs'.
This classification, officials said, allows the department to regulate and ensure the safety of blood products through the same stringent standards applied to pharmaceuticals. By doing so, the department aims at strengthening the safety protocols related to blood donation, storage and transfusion, ensuring that all blood products meet the required quality standards and pose no risk to public health, they added.
If blood bank facilities are not monitored, it may lead to violations, including improper storage conditions such as blood being kept at incorrect temperatures, which can cause contamination or spoilage. Another major risk is inadequate screening of blood for infectious diseases such as HIV, hepatitis, or syphilis, leading to potential transmission of these infections through transfusions.
Additionally, violations can occur while labelling and tracking blood donations, which could result in mix-ups or administering wrong blood groups to patients, the officials said.
A senior official told TNIE that the aim is to ensure rigorous hygiene and cleanliness standards in collection, storage and distribution of blood and its components. The department will focus on ensuring that blood is drawn from qualified professionals under sanitary conditions to minimise any risk to public health. In line with statutory requirements, all blood samples will undergo compulsory testing to ensure they are safe for transfusion.
The official highlighted the importance of maintaining accurate records and ensuring consistency between online data and physical stock. 'The drive involves cross-checking records of blood donations, tallying figures from blood banks, and verifying that they match with the data in the online system,' the official said.
He said efforts are on to ensure that blood donated at government-supported camps is provided to those in need of it.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
15 hours ago
- Time of India
The importance of saying no to drugs: Protecting health and well-being
Dr Edmond Fernandes is a physician and Founder of CHD Group - a global public health organization holding UNECOSOC Special Consultative Status. He is also the Director at Edward & Cynthia Institute of Public Health in Mangalore and empaneled Consultant to UNESCAP and External Consultant to NHSRC, Ministry of Health and Family Welfare, Government of India. Additionally, Dr. Edmond is a Senior Fellow with the Atlantic Council and a US Department of State Alumni. He can be reached on office@ LESS ... MORE In today's fast-paced world, the pressure to experiment with drugs can be overwhelming, especially for young people navigating social, academic, and personal challenges. The allure of drugs—whether recreational, prescription, or illicit—often comes with promises of escape, euphoria, or enhanced performance. However, the consequences of drug use far outweigh any temporary benefits, impacting physical health, mental well-being, relationships, and future opportunities. Saying 'no' to drugs is not just about resisting peer pressure; it's about safeguarding one's health, preserving mental clarity, and building a foundation for a fulfilling life. Immediate health risks Drug use, even in small amounts, can have immediate and severe consequences for physical health. Many substances, such as alcohol, marijuana, cocaine, or opioids, alter the body's natural processes, leading to short-term risks like impaired coordination, heart palpitations, or respiratory issues. For example, stimulants like cocaine can cause heart attacks or strokes, even in first-time users, while depressants like alcohol can lead to alcohol poisoning, which can be fatal. Inhalants, often found in household products, can cause sudden sniffing death syndrome, where the heart stops abruptly due to chemical exposure. Long-term health consequences The long-term effects of drug use are even more alarming. Chronic use of substances like tobacco, alcohol, or methamphetamine can lead to organ damage, including liver cirrhosis, lung cancer, or severe dental decay (often referred to as 'meth mouth'). Opioids, which have fueled a global epidemic, can cause respiratory failure and increase the risk of overdose with prolonged use. Additionally, drugs like marijuana, while sometimes perceived as 'safe,' can impair lung function and increase the risk of chronic bronchitis when smoked regularly. Injectable drugs, such as heroin, carry additional risks like hepatitis C and HIV due to needle sharing. Furthermore, many drugs disrupt the body's immune system, making users more susceptible to infections and diseases. The physical toll of drug use not only shortens life expectancy but also diminishes quality of life, leading to chronic pain, fatigue, and disability. Impact on the brain Substances like cocaine, methamphetamine, and even excessive alcohol consumption can alter brain chemistry, affecting areas responsible for decision-making, memory, and emotional regulation. For adolescents and young adults, drug use can have lifelong consequences, impairing cognitive development and enhances the risk of mental health disorders. Over time, addiction can rewire the brain's reward system, making it difficult for users to experience pleasure without drugs, perpetuating a cycle of dependency. Mental health consequences: Long-term use of drugs like methamphetamine or cocaine can lead to psychosis, characterized by delusions and erratic behavior. Even prescription drugs, when misused, can exacerbate or cause mental health conditions such as depression or bipolar disorder. Addiction itself is classified as a mental health disorder, as it involves compulsive behavior despite harmful consequences Emotional consequences Beyond clinical disorders, drug use can erode emotional stability. Users often experience strained relationships with family and friends, leading to feelings of guilt and loneliness. The pursuit of drugs can dominate one's life, causing individuals to neglect hobbies, goals, and personal values. This loss of identity can lead to a diminished sense of self-worth, making it harder to break free from the cycle of addiction. Moreover, the emotional highs promised by drugs are fleeting, often followed by crashes that leave users feeling worse than before. This rollercoaster of emotions can make it difficult to maintain healthy coping mechanisms, leading to a reliance on substances to manage stress or sadness. Impact on relationships Drug use doesn't just affect the individual; it ripples out to their social circle. Family members often bear the brunt of a loved one's addiction, experiencing emotional distress, financial strain, and sometimes physical harm. Trust is eroded as users may lie, steal, or manipulate to sustain their habit. Romantic relationships can crumble under the weight of secrecy and unreliability, while friendships may dissolve as non-users distance themselves from risky behaviors. For young people, peer pressure can be a significant factor in initiating drug use, but it can also work in reverse: saying no to drugs can strengthen relationships with those who share similar values. Choosing sobriety often means choosing healthier, more supportive social networks, which can enhance one's sense of belonging and purpose. Social stigma and isolation Society often stigmatizes drug users, which can lead to further isolation. Those struggling with addiction may face judgment from employers, educators, or community members, making it harder to seek help or reintegrate after recovery. This stigma can perpetuate a cycle of shame and substance use, as individuals feel trapped by their circumstances. Saying no to drugs helps individuals avoid this social fallout, allowing them to maintain their reputation and connections. It also sets a positive example for others, particularly younger siblings or peers, fostering a culture of health and responsibility. International Day against Drug Abuse and Illicit Trafficking is marked on 26th June every year. This is a time to revisit emergent policies and social developments in society and also to support young people who are very vulnerable to drug use. The growing peer pressure in schools and colleges, often fueled by social media is leading to young people going astray. The responsibility to safeguard our youth from drugs becomes a collective responsibility of elders who care for each other, care for their children and care for a better world. We must look at youth who consume drugs with empathy and provide solutions that take them out of such toxic situations. Often so, as elders we tend to blame them and to point a finger. Social and commercial determinants of health must serve to focus on solutions that make societies better and we must collectively rise up to this quest for a better world. Facebook Twitter Linkedin Email Disclaimer Views expressed above are the author's own.
The Hindu
16 hours ago
- The Hindu
New ‘weight-loss' drugs have lower impact in real life compared to clinical trial results: study
A recent study done in the U.S. showed that semaglutide and tirzepatide — injectable GLP-1 drugs for obesity — produce lower weight loss in a real-world setting, than during the clinical trial, because patients discontinue treatment or use lower maintenance dosages. The results were published by researchers from the Cleveland Clinic, Ohio, U.S., in the peer-reviewed journal Obesity on June 10. Semaglutide and tirzepatide are FDA-approved medications for the treatment of type 2 diabetes and chronic weight management and are now also available in India. Hamlet Gasoyan et al accessed electronic health record data from a large health system in Ohio and Florida to identify adults with overweight or obesity without type 2 diabetes who started with injectable semaglutide or tirzepatide between 2021 and 2023. They recorded early discontinuation (within 3 months) and late discontinuation (within 3–12 months) along with weight reduction. The researchers observed that treatment discontinuation and use of lower maintenance dosages might reduce the likelihood of achieving clinically-meaningful weight reduction in patients on these drugs. Researchers also identified the factors associated with higher odds of achieving a weight loss of 10% or more, after one year of treatment — continuing medications or discontinuing late (vs. early), taking a high maintenance dosage, getting tirzepatide (vs. semaglutide) and were female (vs. male). Commenting on the results of the study, V. Mohan, senior diabetologist, and chairman, Dr. Mohan's Diabetes Specialties Centre, Chennai, who has initiated patients on weight-loss drugs, says: 'The findings are not surprising because in a randomised clinical trial (RCT), there is constant follow up with the participants to continue with the drug regimen. On the other hand, in the real world, especially if patients buy their own medication, they often stop the drug. Even otherwise, compliance rates in real world are much poorer than in an RCT. The bottom line is that these drugs work as long as they are taken. That is how it is with most drugs, if you stop statins, for instance, cholesterol levels go up; if you stop anti-diabetic drugs or BP drugs, the sugar and BP go up.' 'A reality check' Anoop Misra, who heads Fortis C-DOC Hospital for Diabetes and Allied Sciences in Delhi, who has also put his patients on these class of drugs, says: 'This study gives us a reality check of weight loss and blood sugar lowering effects of these drugs. It is important to note that discontinuation of such drugs is likely to be more in India, driven also by cost concerns. Non-compliance to diet and exercise are additional reasons to be considered in India which may cause lower weight loss.' 'Our findings about the real-world use patterns of these medications and associated clinical outcomes could inform the decisions of healthcare providers and their patients on the role of treatment discontinuation and maintenance dosage in achieving clinically meaningful weight reductions,' said Dr. Gasoyan.
&w=3840&q=100)
First Post
a day ago
- First Post
Breakthrough in hunt for AIDS treatment: Scientists develop new mRNA technique for permanent HIV treatment
A paper published in Nature Communications says that scientists at the Peter Doherty Institute for Infection and Immunity in Melbourne have tapped into mRNA technology to locate the AIDS virus and thereby fully clear it from an infected body read more Scientists have seemed to have found a breakthrough in curing the deadly HIV AIDS, which will force the virus out of blood cells. The possible cure tackles the HIV's ability to conceal itself in white blood cells, capable of reactivation, rendering any treatment or drug useless to deal with the virus. A paper published in Nature Communications says that scientists at the Peter Doherty Institute for Infection and Immunity in Melbourne have tapped into mRNA technology to locate the AIDS virus and thereby fully clear it from an infected body. STORY CONTINUES BELOW THIS AD For the first time, researchers have demonstrated that mRNA can be delivered into the cells harbouring hidden HIV by encasing it in a specially designed microscopic fat bubble. Once inside, the mRNA prompts the cells to expose the dormant virus. Dr Paula Cevaal, the co-author of the study, said the employment of mRNA technology in the type of white blood cell that is home to HIV was earlier thought to be 'impossible' as those cells did not take up the fat bubbles, or lipid nanoparticles (LNPs) that are used to carry them. Our hope is that this new nanoparticle design could be a new pathway to an HIV cure,' Cevaal said, adding that her team has developed a new type of LNP that those cells will accept, known as LNP X. However, more research is required to determine whether merely exposing the virus is sufficient for the immune system to eliminate it, or if this approach needs to be paired with other treatments to fully eradicate HIV from the body. 'In the field of biomedicine, many things eventually don't make it into the clinic – that is the unfortunate truth; I don't want to paint a prettier picture than what is the reality. But in terms of specifically the field of HIV cure, we have never seen anything close to as good as what we are seeing, in terms of how well we are able to reveal this virus,' Cevaal said. STORY CONTINUES BELOW THIS AD
